CoChat

Redistribution of accumulated cell iron: a modality of chelation with therapeutic implications

Sohn, Yang-Sung, Breuer, William, Munnich, Arnold, Cabantchik, Z. Ioav · 2008 · Blood

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Abstract

Various pathologies are characterized by the accumulation of toxic iron in cell compartments. In anemia of chronic disease, iron is withheld by macrophages, leaving extracellular fluids iron-depleted. In Friedreich ataxia, iron levels rise in the mitochondria of excitable cells but decrease in the cytosol. We explored the possibility of using deferiprone, a membrane-permeant iron chelator in clinical use, to capture labile iron accumulated in specific organelles of cardiomyocytes and macrophages and convey it to other locations for physiologic reuse. Deferiprone's capacity for shuttling iron between cellular organelles was assessed with organelle-targeted fluorescent iron sensors in conjunction with time-lapse fluorescence microscopy imaging. Deferiprone facilitated transfer of iron from extracellular media into nuclei and mitochondria, from nuclei to mitochondria, from endosomes to nuclei, and from intracellular compartments to extracellular apotransferrin. Furthermore, it mobilized iron from iron-loaded cells and donated it to preerythroid cells for hemoglobin synthesis, both in the presence and in the absence of transferrin. These unique properties of deferiprone underlie mechanistically its capacity to alleviate iron accumulation in dentate nuclei of Friedreich ataxia patients and to donate tissue-chelated iron to plasma transferrin in thalassemia intermedia patients. Deferiprone's shuttling properties could be exploited clinically for treating diseases involving regional iron accumulation.

Overview

Integrity signals

Registry

Crossref · 10.1182/blood-2007-07-102335

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 57 references

Research works printed but not linked: 1

  1. Evans, 1992, The effect of alpha-ketohydroxypyridine chelators on transferrin saturation in vitro and in vivo., Drugs Today (Barc), 28, 19

Cited by

See all 167

Metadata

Authors
Sohn, Y.-S., Breuer, W., Munnich, A., & Cabantchik, Z. I.
Affiliations
  • Hebrew University of Jerusalem (IL)
  • Clinical Research Unit, Medical Genetic Clinic and Research Unit, Inserm Unite 781, Hôpital Necker-Enfants-Malades and Université Paris V René Descartes, Paris, France
Venue
Blood
Published
2008-02-01
Volume
111
Issue
3
Pages
1690-1699
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2055981765
Cited by
167
References
55
Citations by year
2026: 3 · 2025: 3 · 2024: 7 · 2023: 13 · 2022: 5 · 2021: 12 · 2020: 8 · 2019: 9 · 2018: 9 · 2017: 9 · 2016: 9 · 2015: 8 · 2014: 11 · 2013: 11 · 2012: 10
FWCI
6.39
Type
journal article
Language
en
Open access
closed
Locations
  • Blood (publishedVersion)
  • PubMed (publishedVersion)
Funders
Universität Duisburg-Essen
Topics
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
  • Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
Keywords
deferiprone, iron chelation, iron redistribution, labile iron, Friedreich's ataxia, thalassemia intermedia, cardiomyocytes, macrophages, mitochondrial iron, endosomes, apotransferrin, transferrin, anemia of chronic disease, hemoglobin synthesis
MeSH terms
Animals, Cell Line, Cell Nucleus, Hemoglobins, Humans, Iron, Iron Chelating Agents, Mitochondria, Protein Binding, Endosomes, Transferrin, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Redistribution of accumulated cell iron: a modality of chelation with therapeutic implications. https://app.cochat.ai/papers/10.1182/blood-2007-07-102335
The paper
Sohn, Y.-S., Breuer, W., Munnich, A., & Cabantchik, Z. I. (2008). Redistribution of accumulated cell iron: a modality of chelation with therapeutic implications. Blood. https://doi.org/10.1182/blood-2007-07-102335

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.